Kronos Bio

Research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. Learn more

Launch date

Nov 2017

Employees

Market cap

Enterprise valuation

(€47m) (Public information from Sep 2024)

San Mateo California (HQ)

http://www.kronosbio.com/

https://twitter.com/kronosbio https://www.linkedin.com/company/kronos-bio-inc

View job openings

Authorizing premium user...